中国药品政策Pharmaceutical Pricing An Empirical Study of Market.pdf

PharmacoEconomics (2014) 32:293–303 DOI 10.1007/s40273-013-0099-5 ORIGINAL RESEARCH ARTICLE Pharmaceutical Pricing: An Empirical Study of Market Competition in Chinese Hospitals Jing Wu • Judy Xu • Gordon Liu • Jiuhong Wu Published online: 5 November 2013 Springer International Publishing Switzerland 2013 Abstract local manufacturers are not only significantly lower than Background High pharmaceutical prices and over-pre- those of global manufacturers, but are also lower than their scribing of high-priced pharmaceuticals in Chinese hospitals non-leading counterparts when other product attributes are has long been criticized. Although policy makers have tried controlled for. to address these issues, they have not yet found an effective Conclusion Under the highly price-regulated market in balance between government regulation and market forces. China, competition from generic and therapeutic competi- Objective Our objective was to explore the impact of tors did decrease pharmaceutical prices. Further research is market competition on pharmaceutical pricing under Chi- needed to explore whether this competition increases nese government regulation. consumer welfare in China’s healthcare setting. Methods Data from 11 public tertiary hospitals in three cities in China from 2002 to 2005 were used to explore the Key Points for Decision Makers effect of generic and therapeutic competition on prices of antibiotics and cardiovascular products. A quasi-hedonic • Market competition still plays an important role in re